Search by Drug Name or NDC
NDC 00078-0666-15 Mekinist 0.5 mg/1 Details
Mekinist 0.5 mg/1
Mekinist is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is TRAMETINIB DIMETHYL SULFOXIDE.
MedlinePlus Drug Summary
Trametinib is used alone or in combination with dabrafenib (Tafinlar) to treat a certain types of melanoma (a type of skin cancer) that cannot be treated with surgery or that has spread to other parts of the body. It is used in combination with dabrafenib to treat and prevent the return of a certain type of melanoma after surgery to remove it and any affected lymph nodes. Trametinib is also used in combination with dabrafenib to treat a certain type of non-small-cell lung cancer (NSCLC) that has spread to nearby tissues or to other parts of the body. It is used in combination with dabrafenib to treat a certain type of thyroid cancer that has spread to nearby tissues or to other parts of the body, which cannot be treated with other therapies. Trametinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells. =
Related Packages: 00078-0666-15Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Trametinib
Product Information
| NDC | 00078-0666 |
|---|---|
| Product ID | 0078-0666_58ebc072-df4c-4e0e-86ff-5c992a0ab1c1 |
| Associated GPIs | 21533570100310 |
| GCN Sequence Number | 071036 |
| GCN Sequence Number Description | trametinib dimethyl sulfoxide TABLET 0.5 MG ORAL |
| HIC3 | V3U |
| HIC3 Description | ANTINEOPLASTIC - MEK1 AND MEK2 KINASE INHIBITORS |
| GCN | 34726 |
| HICL Sequence Number | 040361 |
| HICL Sequence Number Description | TRAMETINIB DIMETHYL SULFOXIDE |
| Brand/Generic | Brand |
| Proprietary Name | Mekinist |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | trametinib |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | TRAMETINIB DIMETHYL SULFOXIDE |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Pharmaceutical Class | Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA204114 |
| Listing Certified Through | 2023-12-31 |
Package
NDC 00078-0666-15 (00078066615)
| NDC Package Code | 0078-0666-15 |
|---|---|
| Billing NDC | 00078066615 |
| Package | 30 TABLET, FILM COATED in 1 BOTTLE (0078-0666-15) |
| Marketing Start Date | 2016-03-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |